Valuation: Becton, Dickinson and Company

Market Cap 41.51B 36.28B 33.53B 30.98B 58.34B 3,987B 59.4B 400B 157B 1,952B 156B 152B 6,723B P/E 2026 *
37.5x
P/E 2027 * 29x
Enterprise Value 57.45B 50.21B 46.41B 42.88B 80.75B 5,519B 82.22B 554B 217B 2,702B 216B 211B 9,305B EV / Sales 2026 *
2.99x
EV / Sales 2027 * 2.82x
Free-Float
74.04%
Yield 2026 *
2.56%
Yield 2027 * 2.6%
1 day+0.35%
1 week-3.61%
Current month-0.45%
1 month+3.02%
3 months-3.26%
6 months-27.37%
Current year-22.37%
1 week 148.23
Extreme 148.23
154.93
1 month 140.11
Extreme 140.11
159.49
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
287.32
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
07-02Tax

Executive/Senior Manager

-1,935 0.0007%
06-26Sell

Executive/Senior Manager

-75 0.0000%
06-24Sell

Executive/Senior Manager

-1,100 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.53%-3.61%-14.93%-41.92% 41.51B
-0.68%-7.18%-32.62%-17.58% 155B
+1.37%-5.40%-11.62%-9.53% 102B
-0.72%-0.72%+1.76%+57.91% 58.81B
-0.94%+5.94%+39.64%+55.35% 52.82B
+1.53%-10.11% - - 32.69B
+0.34%+0.75%-13.14%-46.02% 28.6B
-0.48%+0.44%+59.32%-7.14% 25.27B
-0.16%-3.09%-7.56%-8.88% 20.34B
-0.32%+8.30%-4.43%-18.03% 20.99B
Average -0.05%-2.41%+1.82%-3.98% 53.75B
Weighted average by Cap. -0.06%-3.95%-7.49%-2.29%

Financials

2026 *2027 *
Net sales 19.2B 16.78B 15.51B 14.33B 26.99B 1,844B 27.48B 185B 72.58B 903B 72.13B 70.54B 3,110B 19.7B 17.22B 15.92B 14.71B 27.69B 1,892B 28.19B 190B 74.47B 927B 74.01B 72.37B 3,191B
Net income 1.12B 983M 909M 839M 1.58B 108B 1.61B 10.83B 4.25B 52.9B 4.22B 4.13B 182B 1.45B 1.27B 1.17B 1.08B 2.04B 139B 2.07B 13.96B 5.48B 68.16B 5.44B 5.32B 235B
Net Debt 15.94B 13.93B 12.88B 11.9B 22.41B 1,531B 22.81B 154B 60.26B 750B 59.89B 58.56B 2,582B 14.03B 12.26B 11.34B 10.47B 19.73B 1,348B 20.08B 135B 53.05B 660B 52.71B 51.55B 2,273B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
15/07/26 US$150.65 -2.07% 1,908,103
13/07/26 US$153.83 +1.24% 1,403,825
10/07/26 US$151.94 +0.72% 1,048,174
09/07/26 US$150.85 +0.19% 1,788,623
08/07/26 US$150.56 -3.67% 2,287,663
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
150.65USD
Average target price
177.08USD
Spread / Average Target
+17.55%

Quarterly revenue - Rate of surprise